Capricor Therapeutics reported $29.16M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Bioline Rx USD 3.87M 386K Jun/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 63.61B 1.3B Sep/2026
Cytokinetics USD 214.64M 6.85M Sep/2026
Geron USD 54.46M 15.67M Sep/2026
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
J&J USD 18.93B 1.09B Sep/2026
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Prothena USD 19.7M 5.6M Jun/2026
PTC Therapeutics USD 211.54M 15.12M Jun/2026
Sarepta Therapeutics USD 390.39M 2.43M Sep/2026